Clinical Trial Design
According to clinical documents, from 3057 patients; 59 of them met the
inclusion criteria, were scheduled for clinic visit screening, and
enrolled in the study. Participants were randomly allocated into the
celery (n=29) and placebo (n=30) groups. In the first step of the
cross-over trial, 8 patients were excluded due to a change in medication
regimen, and a remarkable change in physical activity and discontinuing
(Figure 2). Hence, 51 patients were crossed over and completed the
clinical trial.